Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Leukemia 2Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Preleukemia 1Neurodevelopmental Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Glioblastoma 1Fragile X Syndrome 1DiGeorge Syndrome 1Depression 1Cytopenia 1Bone Marrow Diseases 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1Anemia 122q11 Deletion Syndrome 1

Interventions

Therapeutics 29Psychiatric Rehabilitation 20Cognitive Behavioral Therapy 12Early Intervention, Educational 10Psilocybin 9Ketamine 9Methods 8Saline Solution 7Yoga 6Surveys and Questionnaires 6Mindfulness-Based Cognitive Therapy 6Esketamine 6Counseling 6Psychosocial Intervention 5Mindfulness 5Methylphenidate 5Educational Status 5Behavior Therapy 5Acupuncture Therapy 5Interviews as Topic 4Exercise Therapy 4Exercise 4Escitalopram 4Control Groups 4Caregivers 4Psychotherapy 3Palliative Care 3Niacin 3Mindfulness-Based Stress Reduction 3Melatonin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Depression × Sertraline × Clear all
NCT00066859 2021-09-09

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

Wake Forest University Health Sciences

Phase 3 Completed
2 enrolled

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡